Você procurou por: etorikoksibiannoksella (Finlandês - Inglês)

keskeyttämisiä oli enemmän etorikoksibiannoksella 90 mg kuin annoksella 60 mg.
in the individual medal program studies, for etoricoxib (60 mg or 90 mg), the absolute incidence of discontinuation in any treatment group was up to 2.6% for hypertension, up to 1.9% for edema, and up to 1.1% for congestive heart failure, with higher rates of discontinuation observed with etoricoxib 90 mg than etoricoxib 60 mg.

tulokset kliinisistä tutkimuksista osoittivat, että 90 mg: n kerran päivässä otettavalla etorikoksibiannoksella oli kliinisesti merkittävä hoitovaikutus nivelreuman ja selkärankareuman hoidossa.
data from clinical studies showed clinically meaningful treatment effect for the 90mg etoricoxib once daily dose for both ra and as indications; however, some data are available to indicate that lower doses might also show effect.

erikseen tarkasteltuna vahvistettujen vakavien tromboottisten kardiovaskulaaristen haittatapahtumien suhteellinen vaara oli sama, kun etorikoksibiannoksena oli 60 mg tai 90 mg ja diklofenaakkiannoksena 150 mg.
when considered separately, the relative risks for confirmed thrombotic cardiovascular serious adverse events with etoricoxib 60 mg or 90 mg compared with diclofenac 150 mg were similar.